Archives
-
ACE2 Activation via Diminazene Aceturate Protects Against Se
2026-07-30
This study demonstrates that pharmacological activation of ACE2 using Diminazene Aceturate mitigates sepsis-induced cardiomyopathy in mice by enhancing MasR-Sirt1-mediated mitochondrial biogenesis. The findings clarify mechanistic pathways underlying cardiac protection in sepsis, informing new research strategies for targeting mitochondrial dysfunction in infection-driven cardiac injury.
-
CSRP2 Regulates PRC1-Mediated PDGFRA/PI3K/AKT Signaling in G
2026-07-30
This study uncovers a novel regulatory axis in glioblastoma, showing that CSRP2 modulates the PDGFRA/PI3K/AKT pathway via PRC1 complex components. The findings clarify epigenetic mechanisms in mesenchymal gliomas and identify CSRP2 as a potential biomarker, with implications for future targeted therapies.
-
RBMS1 Loss Sensitizes TNBC to PD-L1 Blockade via Glycosylati
2026-07-29
The reference study uncovers RBMS1 as a crucial post-transcriptional regulator of PD-L1 stability in triple-negative breast cancer (TNBC), revealing that RBMS1 loss destabilizes B4GALT1 mRNA and reduces PD-L1 glycosylation. This mechanism enhances anti-tumor T cell responses and potentiates immune checkpoint therapy, informing new combinatorial immunotherapy strategies.
-
Prestained Protein Marker (Triple color, EDTA free, 10-250 k
2026-07-29
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides visible, multi-color molecular weight standards for SDS-PAGE and Western blot workflows, enabling real-time protein separation monitoring and transfer verification without EDTA interference. It should be used where precise band tracking, phosphoprotein compatibility, and fluorescent membrane imaging are required, but is not suitable when unstained markers or non-overlapping molecular weight ranges are essential.
-
TBK1 Inhibition Alleviates Painful Diabetic Neuropathy via M
2026-07-28
Liao et al. (2024) demonstrate that targeting TANK-binding kinase 1 (TBK1) reduces painful diabetic neuropathy (PDN) by suppressing microglia-mediated pyroptosis. This mechanistic insight identifies TBK1 inhibition as a promising strategy for addressing neuroinflammatory complications in diabetes models.
-
Structural Insights into Tiamulin-Ribosome Interaction and R
2026-07-28
This article analyzes the 2006 study that elucidates how tiamulin and other pleuromutilin antibiotics bind the ribosomal peptidyl transferase center, uncovering structural bases for both drug action and resistance. These findings directly inform rational design of improved veterinary antibiotics and help guide laboratory applications in research and clinical contexts.
-
I-BET151 (GSK1210151A): Technical Guidance for BET Inhibitio
2026-07-27
I-BET151 (GSK1210151A) is designed for researchers investigating BET protein function, transcriptional regulation, and oncogenic pathways—especially in cancer biology and apoptosis studies. It is not suited for diagnostic or therapeutic applications, and strict adherence to storage and handling protocols is required to ensure data reproducibility.
-
Bile Acid Retention Impairs Antigen Presentation in MASH-HCC
2026-07-27
This study reveals that bile acid retention within tumor cells suppresses NLRC5-mediated MHC-I antigen presentation, enabling immune evasion in metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma (MASH-HCC). By elucidating the GPR120–bile acid–NLRC5 axis, the work identifies novel targets for restoring tumor immunogenicity and improving immunotherapy outcomes.
-
Viral Degradation of RIPK3 Modulates Necroptosis and Inflamm
2026-07-26
This study uncovers a class of orthopoxvirus proteins (vIRD) that target the necroptosis adaptor RIPK3 for ubiquitin-mediated degradation, suppressing necroptosis and reshaping the host inflammatory response. These findings reveal a mechanistic link between viral immune evasion and the SCF ubiquitin ligase complex, offering new insights into host-pathogen interactions.
-
IBDV VP3 Protein Drives IRF7 Degradation via the Proteasome
2026-07-25
This study uncovers how infectious bursal disease virus (IBDV) exploits its VP3 protein to degrade interferon regulatory factor 7 (IRF7) via the proteasome pathway, suppressing the antiviral interferon response in chicken cells. These findings reveal a previously unknown viral immune evasion mechanism with implications for poultry immunology and antiviral research.
-
Adipose-Neural Axis and NPY/Y1R in EAT-Linked Cardiac Arrhyt
2026-07-24
Fan et al. (2024) provide a mechanistic link between epicardial adipose tissue and cardiac arrhythmias, uncovering the role of the adipose-neural axis via leptin and neuropeptide Y/Y1 receptor signaling. Their stem cell-based coculture model identifies actionable molecular targets and establishes a robust experimental system for future cardiovascular and neuropeptide research.
-
Scalable iMSC-EV Production for Pulmonary Fibrosis Therapy
2026-07-24
Gong et al. introduce a robust, bioreactor-based platform for scalable production of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) from extended pluripotent stem cells (EPSCs). This innovation delivers high-yield, standardized EVs with therapeutic efficacy in a preclinical pulmonary fibrosis model, addressing key challenges of donor variability and clinical translation.
-
Polyvalent Vaccine Targets Tumor-Associated Bacteria to Halt
2026-07-23
Kang et al. present a polyvalent vaccine strategy that selectively eliminates tumor-associated bacteria, significantly impeding breast cancer metastasis in preclinical models. This innovation demonstrates the therapeutic potential of modulating the intratumoral microbiome, opening new avenues for metastasis prevention.
-
Bile Acid Retention Suppresses Antigen Presentation in MASH-
2026-07-23
This study uncovers a mechanistic axis by which bile acid retention impairs NLRC5-mediated MHC-I antigen presentation in metabolic dysfunction-associated steatohepatitis (MASH)-related hepatocellular carcinoma (HCC). The findings reveal how metabolic reprogramming enables immune evasion in MASH-HCC and highlight bile acid modulation as a promising therapeutic target for restoring tumor immunogenicity and enhancing immunotherapy efficacy.
-
TiO2-Nanoparticle SDT Prevents PCO via Ferroptosis in HLECs
2026-07-22
This study demonstrates that sonodynamic therapy (SDT) using titanium dioxide nanoparticle–coated intraocular lenses (TiO2-IOLs) effectively prevents posterior capsular opacification (PCO) by inducing ferroptosis in human lens epithelial cells (HLECs). The work provides mechanistic insight into SDT-mediated cell death and highlights potential translational strategies for ocular surgery complications.